Nondisclosure of HIV Status in a Clinical Trial Setting: Antiretroviral Drug Screening Can Help Distinguish Between Newly Diagnosed and Previously Diagnosed HIV Infection
Mark A. Marzinke(Family Health International 360), Jessica M. Fogel(Johns Hopkins University), Susan Buchbinder(University of California, San Francisco), Estelle Piwowar‐Manning(Johns Hopkins University), Autumn Breaud(Johns Hopkins University), Sharon Mannheimer(Columbia University Irving Medical Center), Sam Griffith(Family Health International 360), Sheldon D. Fields(Pennsylvania State University), Steven Shoptaw(University of California, Los Angeles), Beryl A. Koblin(New York Blood Center), Manya Magnus(Milken Institute), Carlos del Rı́o(Emory University), Susan H. Eshleman(Johns Hopkins University), Vanessa Cummings(Johns Hopkins University), Darrell P. Wheeler(Loyola University Chicago), Ting-Yuan Liu(Fred Hutch Cancer Center), William Clarke(Johns Hopkins University), Lei Wang(Shanghai Jiao Tong University), Kenneth H. Mayer(Miriam Hospital)
Cited by 55
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768